The United States, being the largest pharmaceutical market in the world, is one of the key focus areas for the company's growth strategies.

To drive business in this market, Wockhardt established its own sales and marketing organisation, Wockhardt USA Inc. With this setup, the company will be able to capture value from end to end of the supply chain. Wockhardt’s US business is fast growing business with a growth of over 50 %.

The company has done and is continuing to do substantial work in this regard. Wockhardt now has 23 products being marketed under its own label with more than 50 in different stages of developmental pipeline.

Morton Grove, USA

Morton Grove Pharmaceuticals is a liquid generic and specialty Dermatology Company in USA located at Morton Grove, Illinois.

Morton Grove is a strategic acquisition of Wockhardt. It provides entry into the US generic market with a portfolio of 31 products, 13 of which occupy the No.1 market position. The acquisition would boost Wockhardt’s US revenue by providing a complete range of dosage forms tablets, capsules, liquids to injectibles.

For more information on Wockhardt USA, click here >> www.wockhardtusa.com

Kindly email us at contactusa@wockhardt.com